Proteome Sciences plc (FRA:PI2)

Market Cap	5.58M -45.8%
Revenue (ttm)	4.31M -23.1%
Net Income	-3.51M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0030
Previous Close	0.0025
Day's Range	0.0030 - 0.0030
52-Week Range	0.0015 - 0.0445
Beta	n/a
RSI	42.29
Earnings Date	Jun 25, 2026

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling p...

• Industry: Commercial Physical and Biological Research
• Founded: 1993
• Employees: 36
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PI2

Financial Performance

In 2025, Proteome Sciences's revenue was 3.76 million, a decrease of -23.14% compared to the previous year's 4.89 million. Losses were -3.06 million, -10.13% less than in 2024.

Financial numbers in GBP